KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) FCF Payout Ratio: 2019-2025

Historic FCF Payout Ratio for Royalty Pharma (RPRX) over the last 6 years, with Sep 2025 value amounting to -0.13.

  • Royalty Pharma's FCF Payout Ratio fell 109.29% to -0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17, marking a year-over-year increase of 130.09%. This contributed to the annual value of 0.48 for FY2024, which is 246.90% up from last year.
  • Royalty Pharma's FCF Payout Ratio amounted to -0.13 in Q3 2025, which was down 224.29% from 0.11 recorded in Q2 2025.
  • In the past 5 years, Royalty Pharma's FCF Payout Ratio registered a high of 5.46 during Q1 2021, and its lowest value of -0.72 during Q4 2021.
  • Its 3-year average for FCF Payout Ratio is 0.00, with a median of 0.06 in 2023.
  • Its FCF Payout Ratio has fluctuated over the past 5 years, first soared by 1,157.68% in 2021, then crashed by 881.20% in 2024.
  • Quarterly analysis of 5 years shows Royalty Pharma's FCF Payout Ratio stood at -0.72 in 2021, then spiked by 114.34% to 0.10 in 2022, then tumbled by 202.85% to -0.11 in 2023, then skyrocketed by 219.81% to 0.13 in 2024, then slumped by 109.29% to -0.13 in 2025.
  • Its last three reported values are -0.13 in Q3 2025, 0.11 for Q2 2025, and 0.09 during Q1 2025.